Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NG2-73 begins phase II study in chronic insomnia patients

Nov. 2, 2006

Satori Pharmaceuticals' SPI-014 exhibits Abeta42-lowering activity in vitro and in vivo

Nov. 2, 2006

Novel cannabinoid agonists reported by Adolor

Nov. 2, 2006

Recent Pfizer patent describes new dopamine D2 receptor ligands for schizophrenia

Oct. 31, 2006

Emerging natural products for the treatment of neurological disorders: Part I

Oct. 31, 2006

Nicotinamide protects against axonal degeneration in MS model / News in Context

Oct. 31, 2006

Strattera improves ADHD symptoms in subjects with reading disorder

Oct. 31, 2006

Daytrana shown to give individualized ADHD symptom management

Oct. 31, 2006

Free radical scavenger Iacvita provides benefit in an animal model of stroke

Oct. 30, 2006

Preclinical profile of Wyeth's 5-HT2C agonist SCA-136 updated

Oct. 30, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026